CVE-2023-37412
MEDIUMCVSS 4.9/10EPSS 0.25%
Last modified
CVE-2023-37412 is a medium-severity vulnerability rated 4.9/10 on the CVSS scale. IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.. EPSS estimates a 0.25% chance of exploitation in the next 30 days.
Description
IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.
Metrics
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:H/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Ibm | Aspera Faspex | >= 5.0.0, <= 5.0.10 |
References
- https://www.ibm.com/support/pages/node/7181814Vendor Advisory
Timeline
- Published
- Last Modified
- Status
- Analyzed
Frequently Asked Questions
What is CVE-2023-37412?
IBM Aspera Faspex 5.0.0 through 5.0.10 could allow a privileged user to make system changes without proper access controls.
How severe is CVE-2023-37412?
CVE-2023-37412 has a CVSS score of 4.9/10 (MEDIUM severity). The EPSS model estimates a 0.25% probability of exploitation in the next 30 days.
How do I fix CVE-2023-37412?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-37412?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST